摘要
肿瘤疾病已成为我国居民主要死亡原因,由于其病情重、病程长、治疗费用高的特点,给医疗保险造成沉重负担。为规范新型抗肿瘤药物的临床使用,中华人民共和国国家卫生健康委员会从2018年开始逐年发布《新型抗肿瘤药物临床应用指导原则》,本文就2021年版进行内容解读,同时对原则编写提供个人意见和见解。
Cancer has been the most popular cause of death of Chinese residents.Because of its serious illness,long course of disease and high treatment cost,it resulted in a heavy burden of the medical insurance system.National health commission of the People’s Republic of China issues the Guiding Principles of the Clinical Use of New Antitumor Medicines to normalize the application of the drugs year by year from 2018.This paper interprets the 2021 edition and provides personal opinions and opinions of the principles.
作者
刘家伟
孔维华
董子询
冯佳佳
林丽开
LIU Jia-wei;KONG Wei-hua;DONG Zi-xun;FENG Jia-jia;LIN Li-kai(Institute of Hospital Management,Wuhan University,Wuhan 430071,China)
出处
《临床药物治疗杂志》
2022年第3期1-5,共5页
Clinical Medication Journal
